Related Experiment Video

Updated: Aug 8, 2026

Spheroid Assay to Measure TGF-β-induced Invasion
09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma

Shi-Long Lu1, Heather Herrington, Douglas Reh

  • 1Department of Otolaryngology, OHSU Cancer Institute, Oregon Health and Science University, Portland, OR 97239, USA.

Genes & Development
|May 17, 2006
PubMed

Insights

Developing new treatments for head-and-neck squamous cell carcinoma (HNSCC) is crucial. This study introduces a novel mouse model that mimics human HNSCC, paving the way for improved targeted therapies.

Area of Science:

  • Oncology
  • Cancer Biology
  • Translational Research

Background:

  • Head-and-neck squamous cell carcinoma (HNSCC) prognosis has stagnated for two decades.
  • Lack of accurate animal models impedes HNSCC biomarker validation and targeted therapy development.

Purpose of the Study:

  • To develop a preclinical HNSCC model that recapitulates human disease pathology and molecular features.
  • To investigate the role of oncogenic Ras and TGF-beta signaling in HNSCC development.

Main Methods:

  • Engineered mouse models with activated K-ras or H-ras and deleted transforming growth factor-beta type II receptor (TGFbetaRII) in head-and-neck epithelia.
  • Pathological and molecular characterization of induced tumors.
  • Analysis of the role of endogenous TGFbeta1 in tumor microenvironment.

Main Results:

  • The developed mouse model exhibited HNSCC with complete penetrance, including metastatic cases.
  • Tumors displayed pathology and molecular alterations mirroring human HNSCC.
  • Elevated TGFbeta1 promoted inflammation and angiogenesis within the tumor stroma.

Conclusions:

  • Ras activation combined with TGFbetaRII loss creates a faithful HNSCC model.
  • Targeting oncogenic pathways in tumor cells and TGFbeta1 in the stroma offers a potential dual therapeutic strategy for HNSCC.

More Related Videos

Three-Dimensional (3D) Tumor Spheroid Invasion Assay12:19

Three-Dimensional (3D) Tumor Spheroid Invasion Assay

Published on: May 1, 2015

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...